News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
838,553 Results
Type
Article (86090)
Company Profile (649)
Press Release (751814)
Multimedia
Podcasts (128)
Webinars (14)
Section
Business (232213)
Career Advice (4124)
Deals (39708)
Drug Delivery (126)
Drug Development (90792)
Employer Resources (198)
FDA (17997)
Job Trends (17322)
News (395548)
Policy (39671)
Tag
2024 BioCapital Digital (20)
2024 BioForest Digital (16)
2024 BioForest Standard (1)
2024 BioMidwest Digital (14)
2024 BioMidwest Standard (2)
2024 Bio NC Digital (19)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (20)
2024 Biotech Beach Digital (15)
2024 Biotech Beach Standard (9)
2024 Genetown Digital (10)
2024 Genetown Standard (11)
2024 Lone Star Bio Digital (17)
2024 Pharm Country Digital (13)
2024 Pharm Country Standard (6)
2025 BioForest Digital (7)
2025 Lone Star Bio Digital (8)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Bio NC Standard (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Genetown Standard (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (2)
Academia (2992)
Academic (1)
Accelerated approval (6)
Adcomms (25)
Allergies (78)
Alliances (56656)
ALS (79)
Alzheimer's disease (1467)
Antibody-drug conjugate (ADC) (140)
Approvals (17981)
Artificial intelligence (222)
Autoimmune disease (27)
Automation (12)
Bankruptcy (402)
Best Places to Work (12512)
BIOSECURE Act (22)
Biosimilars (119)
Biotechnology (447)
Bladder cancer (66)
Brain cancer (25)
Breast cancer (226)
Cancer (1945)
Cardiovascular disease (140)
Career advice (3530)
Career pathing (34)
CAR-T (155)
Cell therapy (434)
Cervical cancer (17)
Clinical research (72778)
Collaboration (771)
Compensation (440)
Complete response letters (28)
COVID-19 (2828)
CRISPR (42)
C-suite (216)
Cystic fibrosis (99)
Data (1794)
Decentralized trials (2)
Denatured (45)
Depression (37)
Diabetes (184)
Diagnostics (6751)
Digital health (9)
Diversity (9)
Diversity, equity & inclusion (48)
Drug discovery (118)
Drug pricing (93)
Drug shortages (17)
Duchenne muscular dystrophy (81)
Earnings (95276)
Editorial (36)
Employer branding (25)
Employer resources (167)
Events (128323)
Executive appointments (606)
FDA (18922)
Featured Employer (63)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (645)
Gene editing (97)
Generative AI (22)
Gene therapy (309)
GLP-1 (735)
Government (5107)
Grass and pollen (4)
Guidances (35)
Healthcare (20743)
Huntington's disease (25)
IgA nephropathy (26)
Immunology and inflammation (126)
Indications (24)
Infectious disease (2943)
Inflammatory bowel disease (147)
Inflation Reduction Act (11)
Influenza (43)
Intellectual property (84)
Interviews (812)
IPO (17688)
IRA (38)
Job creations (5185)
Job search strategy (2861)
Kidney cancer (11)
Labor market (41)
Layoffs (537)
Leadership (20)
Legal (10057)
Liver cancer (70)
Lung cancer (285)
Lymphoma (131)
Machine learning (5)
Management (65)
Manufacturing (284)
MASH (68)
Medical device (14298)
Medtech (14303)
Mergers & acquisitions (22272)
Metabolic disorders (590)
Multiple sclerosis (75)
NASH (22)
Neurodegenerative disease (97)
Neuropsychiatric disorders (23)
Neuroscience (1951)
NextGen: Class of 2025 (7666)
Non-profit (5055)
Northern California (2280)
Now hiring (40)
Obesity (317)
Opinion (270)
Ovarian cancer (68)
Pain (65)
Pancreatic cancer (61)
Parkinson's disease (131)
Partnered (19)
Patents (193)
Patient recruitment (91)
Peanut (48)
People (64868)
Pharmaceutical (131)
Pharmacy benefit managers (13)
Phase I (22480)
Phase II (31644)
Phase III (23792)
Pipeline (996)
Policy (138)
Postmarket research (3542)
Preclinical (10099)
Press Release (72)
Prostate cancer (83)
Psychedelics (34)
Radiopharmaceuticals (250)
Rare diseases (354)
Real estate (7383)
Recruiting (75)
Regulatory (26404)
Reports (55)
Research institute (2646)
Resumes & cover letters (649)
Rett syndrome (1)
RNA editing (4)
RSV (34)
Schizophrenia (68)
Series A (125)
Series B (72)
Service/supplier (25)
Sickle cell disease (46)
Southern California (1946)
Special edition (18)
Spinal muscular atrophy (164)
Sponsored (34)
Startups (4285)
State (2)
Stomach cancer (11)
Supply chain (50)
Tariffs (31)
The Weekly (81)
United States (19565)
Vaccines (726)
Venture capitalists (41)
Weight loss (228)
Women's health (37)
Worklife (19)
Date
Today (122)
Last 7 days (492)
Last 30 days (2063)
Last 365 days (29169)
2025 (8199)
2024 (34032)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1265)
Alabama (53)
Alaska (6)
Arizona (244)
Arkansas (8)
Asia (49821)
Australia (8792)
California (5198)
Canada (1552)
China (480)
Colorado (165)
Connecticut (208)
Delaware (124)
Europe (114002)
Florida (647)
Georgia (145)
Hawaii (1)
Idaho (64)
Illinois (438)
India (25)
Indiana (269)
Iowa (9)
Japan (133)
Kansas (109)
Kentucky (16)
Louisiana (8)
Maine (58)
Maryland (828)
Massachusetts (4097)
Michigan (183)
Minnesota (309)
Mississippi (1)
Missouri (53)
Montana (24)
Nebraska (26)
Nevada (52)
New Hampshire (51)
New Jersey (1490)
New Mexico (27)
New York (1470)
North Carolina (993)
North Dakota (7)
Northern California (2280)
Ohio (162)
Oklahoma (13)
Oregon (45)
Pennsylvania (1100)
Puerto Rico (11)
Rhode Island (23)
South America (1648)
South Carolina (4)
South Dakota (1)
Southern California (1946)
Tennessee (30)
Texas (688)
Utah (114)
Virginia (101)
Washington D.C. (39)
Washington State (509)
West Virginia (1)
Wisconsin (38)
838,553 Results for "kala bio".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
KALA BIO Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
April 1, 2025
·
13 min read
Press Releases
KALA BIO Announces Chief Executive Officer Transition
February 13, 2025
·
5 min read
Press Releases
KALA BIO to Present at TD Cowen 45th Annual Health Care Conference
February 26, 2025
·
1 min read
Press Releases
KALA BIO Announces $10,750,000 Private Placement
December 30, 2024
·
5 min read
BioCapital
KALA BIO to Present at Jefferies 2024 Global Healthcare Conference
KALA BIO, Inc. announced that Kim Brazzell, Ph.D., Head of R&D and Chief Medical Officer of KALA BIO, will present at the Jefferies Global Healthcare Conference being held in New York, NY on Wednesday, June 5, 2024 at 12:30 p.m. ET.
May 29, 2024
·
1 min read
Deals
KALA BIO Announces $12,500,000 Private Placement
KALA BIO, Inc. today announced that it has entered into a securities purchase agreement with a select group of institutional accredited investors for the sale, in a private placement, of shares of its common stock and shares of its Series H Convertible Non-Redeemable Preferred Stock (the “Series H Preferred Stock”), for aggregate gross proceeds of approximately $12.5 million, before deducting offering expenses.
June 27, 2024
·
4 min read
Business
KALA BIO Reports First Quarter 2024 Financial Results and Provides Corporate Update
KALA BIO, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of innovative therapies for rare and severe diseases of the eye, today reported financial results for the first quarter ended March 31, 2024 and provided a corporate update.
May 14, 2024
·
11 min read
Press Releases
KALA BIO to Present at Piper Sandler 36th Annual Healthcare Conference
November 27, 2024
·
1 min read
Genetown
KALA BIO to Present at TD Cowen 44th Annual Healthcare Conference
KALA BIO, Inc. (NASDAQ:KALA) today announced that Mark Iwicki, Chair and Chief Executive Officer of KALA BIO, will present a corporate overview at the TD Cowen 44th Annual Healthcare Conference being held in Boston on Monday, March 4, 2024 at 12:50 p.m. ET.
February 26, 2024
·
1 min read
Press Releases
KALA BIO Reports Third Quarter 2024 Financial Results and Provides Corporate Update
November 13, 2024
·
12 min read
1 of 83,856
Next
